⌘K

Login Start Free

Home/Filings/4/0001209191-19-030616

4//SEC Filing

Saks Samuel R 4

Accession 0001209191-19-030616

CIK 0001377121other

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 6:43 PM ET

Size

5.5 KB

Accession

0001209191-19-030616

Insider Transaction Report

Form 4

Period: 2019-05-15

Protagonist Therapeutics, IncPTGX

Chief Development Officer

Transactions

Award
Stock Option (right to buy)
2019-05-15+45,000→ 45,000 total
Exercise: $10.80Exp: 2029-05-14→ Common Stock (45,000 underlying)

Footnotes (1)

[F1]The stock option vests in 48 equal monthly installments following the date of grant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1

filerCIK 0001365615

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 6:43 PM ET
Size: 5.5 KB

View on SEC.gov